Consistent to our report, the gene expression level of SFRP2 was significantly lowest in the tumor area and highest at a 1-cm distance in both proximal and distal sides, indicating that there was a biomolecular response of NAT to inhibit the tumor lateral growth of primary cancer. The gene discussed is BRD2; the disease is cancer.